CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

Cardiac Biotech

CBSC宣布37.5万美元采购订单及循环收入项目

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.

Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案(CBSC)签署覆盖中美洲和南美洲的独家五年分销协议

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

How can we help you?

Tell us what you are interested in.

Contact Us

订阅我们的新闻邮件！

订阅我们的电子报，我们将直接向您发送最新消息。